It was demonstrated that tumor-infiltrating γδ T cells with higher expression of programmed cell death ligand 1 (PD-L1) and Galectin-9 (Gal-9) could inhibit the effector activity of conventional αβ T cells [10,24]. Here, LGALS9 is linked to neoplasm.